Detalhe da pesquisa
1.
Hematologist-Level Classification of Mature B-Cell Neoplasm Using Deep Learning on Multiparameter Flow Cytometry Data.
Cytometry A
; 97(10): 1073-1080, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32519455
2.
Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis.
Eur J Haematol
; 104(2): 125-137, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31758597
3.
Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study.
Acta Oncol
; 60(1): 24-27, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33397179
4.
Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort.
Eur Urol Open Sci
; 53: 31-37, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37441344
5.
Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alteration.
Leukemia
; 36(2): 394-402, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34376804
6.
Knowledge transfer to enhance the performance of deep learning models for automated classification of B cell neoplasms.
Patterns (N Y)
; 2(10): 100351, 2021 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34693376
7.
Molecular characterization of a second myeloid neoplasm developing after treatment for acute myeloid leukemia.
Leukemia
; 34(3): 811-820, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31719678
8.
The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time?
Cancer Genet
; 242: 15-24, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31980417
9.
Molecular characterization of AML with RUNX1-RUNX1T1 at diagnosis and relapse reveals net loss of co-mutations.
Hemasphere
; 3(1): e178, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31723813
10.
Complement and inflammasome overactivation mediates paroxysmal nocturnal hemoglobinuria with autoinflammation.
J Clin Invest
; 129(12): 5123-5136, 2019 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31430258
11.
NPM1 mutated AML can relapse with wild-type NPM1: persistent clonal hematopoiesis can drive relapse.
Blood Adv
; 2(22): 3118-3125, 2018 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30455361
12.
CDK6 Antagonizes p53-Induced Responses during Tumorigenesis.
Cancer Discov
; 8(7): 884-897, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29899063
13.
DNMT3A mutations are over-represented in young adults with NPM1 mutated AML and prompt a distinct co-mutational pattern.
Leukemia
; 33(11): 2741-2746, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209279
14.
Minimal residual disease (MRD) monitoring and mutational landscape in AML with RUNX1-RUNX1T1: a study on 134 patients.
Leukemia
; 32(10): 2270-2274, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29568097